Notice of Intent to Sole Source - American National Standards Institute - ISO 35001:2019 License Agreement
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Centers for Disease Control and Prevention (CDC), specifically the Quality and Safety Systems Branch (QSSB), has issued a Notice of Intent (NOI) to award a sole source, firm fixed-price purchase order to American National Standards Institute, Inc. (ANSI) for an ISO35001:2019 License Agreement. This license is crucial for supporting the Biorisk Management Pilot (BMP) program, a cooperative agreement with the Association of Public Health Laboratories (APHL). Capability statements from interested parties are due by March 9, 2026.
Purpose & Scope
The BMP program aims to enhance internal processes within clinical and public health laboratories, thereby reducing incidents, accidents, infections, and illnesses linked to laboratory operations. The ISO35001:2019 Licensing Agreement is deemed essential by the CDC as it provides a defined process for identifying, assessing, controlling, and monitoring risks associated with hazardous biological materials. ANSI is identified as the sole source provider for this specific license.
Contract Details
- Opportunity Type: Special Notice (Notice of Intent to Sole Source)
- Authority: FAR 6.103-1(b) and 41 U.S.C. 3304(a)(1)
- Procurement Method: Simplified acquisition in accordance with FAR Part 12 - Acquisition of Commercial Products and Commercial Supplies.
- NAICS Code: 541611 - Administrative Management and General Management Consulting Services
- Place of Performance: Atlanta, GA, United States
- Department/Agency: Health And Human Services / CENTERS FOR DISEASE CONTROL AND PREVENTION
Submission & Evaluation
This notice is NOT a request for competitive quotations. However, interested parties who believe they possess the capabilities to fulfill this requirement are encouraged to submit a capability statement demonstrating their abilities. Responses must be emailed to the contract specialist, Felipe Cardenas, at tpp5@cdc.gov by March 9, 2026, at 5:00 PM ET. No phone calls will be accepted. The Government will review responses received within 10 days of the notice's issuance, but the determination not to compete this proposed contract remains at the Government's discretion.
Set-Aside
This is a Notice of Intent to Sole Source and is not subject to a set-aside designation.